On this page you will find all shared care protocols (SCPs) that have been approved by GMMMG for use across Greater Manchester. As we move to a single GM commissioning arrangement, SCPs will be annotated to better define commissioning arrangements.

The GMMMG agreed process for transfer of prescribing responsibilities can be found here. The shared care protocol template includes a section for requesting shared care and letter templates to respond to the shared care request. Copies of these are also available at this link.

GMMMG plan to adopt SCPs produced by the Regional Medicines Optimisation Committee (RMOC), once they are published, as part of the “Shared Care for Medicines Guidance – a Standard Approach”. Until these are published and formally adopted by GMMMG the documentation on this page should continue to be used. GMMMG will continue the development of SCPs which are outside the published RMOC schedule but have been identified as being required by the GMMMG system as shared care medicines.

Any SCPs listed below which have passed their review date will remain in use until an updated GMMMG approved version is available, with only technical updates to address any emerging safety issues. The responsibility for the production and updating of SCPs lies with the originating author in collaboration with the GMMMG Clinical Reference Group (CRG).

GMMMG have created a patient information leaflet to support shared care conversations with patients and carers

Enquiries regarding the development of SCPs can be submitted to nuth.enquires.gmmmg@nhs.net.

The table headings below are active links; click a heading to sort in ascending or descending order.

Drug Document Title BNF Issue Date Review Date Comments
Antipsychotics Antipsychotics for bipolar disorder in children and adolescents 4 20171001 01/10/2017 20201001 01/10/2020
Antipsychotics Antipsychotics for psychosis and schizophrenia in children and adolescents 4 20171001 01/10/2017 20201001 01/10/2020
Antipsychotics Antipsychotics for the treatment of OCD in children and adolescents 4 20171001 01/10/2017 20201001 01/10/2020
Apomorphine Apomorphine use in Parkinson’s disease 4 20181201 01/12/2018 20211201 01/12/2021
Aripiprazole Aripiprazole long-acting antipsychotic injection in adults 4 20170801 01/08/2017 20200801 01/08/2020
Atomoxetine Atomoxetine for ADHD in children and adolescents 4 20170801 01/08/2017 20200801 01/08/2020
Adult ADHD Atomoxetine, dexamfetamine, guanfacine, lisdexamfetamine and methylphenidate for ADHD in adults 4 20200131 31/01/2020 20221001 01/10/2022
Azathioprine & 6-mercaptopurine Azathioprine and 6-mercaptopurine for the treatment of IBD in adults 1 20171101 01/11/2017 20201001 01/10/2020
Azathioprine Azathioprine for autoimmune hepatitis in adults 1 20191101 01/11/2019 20221101 01/11/2022
Azathioprine Azathioprine for IBD in paediatrics 1 20170901 01/09/2017 20180501 01/05/2018
Azathioprine Azathioprine for interstitial lung disease in adults 3 20181001 01/10/2018 20211001 01/10/2021
Azathioprine Azathioprine in dermatology in adults 13 20180201 01/02/2018 20210201 01/02/2021
Azathioprine Azathioprine in neurological conditions in adults 8 20180701 01/07/2018 20210701 01/07/2021
Azathioprine Azathioprine in rheumatological conditions in adults 10 20171101 01/11/2017 20201001 01/10/2020
Ciclosporin Ciclosporin in dermatology in adults 13 20180201 01/02/2018 20210201 01/02/2021
Ciclosporin Ciclosporin in rheumatological conditions in adults 10 20180101 01/01/2018 20201001 01/10/2020
Cinacalcet Cinacalcet for primary hyperparathyroidism in adults 9 20170601 01/06/2017 20200601 01/06/2020
Degarelix Degarelix in advanced hormone dependent prostate cancer in adults 7 20170901 01/09/2017 20200601 01/06/2020
Denosumab Denosumab for osteoporosis in adults 6 20171101 01/11/2017 20201001 01/10/2020
Dexamfetamine Dexamfetamine for ADHD in children and adolescents 4 20170801 01/08/2017 20200801 01/08/2020
Disulfiram Disulfiram in the treatment of alcohol dependence in adults 4 20180801 01/08/2018 20210801 01/08/2021
Domperidone Domperidone for paediatric gastro-oesophageal reflux disease (GORD) 1 20180801 01/08/2018 20210801 01/08/2021
Ethinylestradiol Ethinylestradiol for the induction of delayed puberty 6 20171201 01/12/2017 20201201 01/12/2020
Estradiol Feminising hormones for patients aged 17 years or over under Indigo Gender Service 6 20210301 01/03/2021 20240301 01/03/2024
Antipsychotics First generation (typical) antipsychotic depots in adults 4 20180101 01/01/2018 20180501 01/05/2018 Update in progress
Goserelin, leuprorelin & triptorelin GnRH analogues for patients aged 17 years or over under Indigo Gender Service 6 20210301 01/03/2021 20240301 01/03/2024
Goserelin Goserelin in breast cancer in adults 8 20181001 01/10/2018 20211001 01/10/2021
Growth hormone (somatropin) Growth hormone in paediatrics 6 20200301 01/03/2020 20230301 01/03/2023
Guanfacine Guanfacine for childhood and adolescent ADHD 4 20170901 01/09/2017 20191101 01/11/2019
Hydroxycarbamide Hydroxycarbamide for myleoproliferative disorders in adults 9 20170801 01/08/2017 20200801 01/08/2020
Hydroxycarbamide Hydroxycarbamide for sickle cell disease in adults 9 20170801 01/08/2017 20200801 01/08/2020
Hydroxychloroquine Hydroxychloroquine for rheumatological conditions in adults 10 20171101 01/11/2017 20220401 01/04/2022
Hydroxychloroquine Hydroxychloroquine in dermatology in adults 13 20180201 01/02/2018 20220401 01/04/2022
Ibandronate Ibandronate for breast cancer in adults 6 20170901 01/09/2017 20200601 01/06/2020
Leflunomide Leflunomide for rheumatological conditions in adults 10 20171101 01/11/2017 20201001 01/10/2020
Goserelin, leuprorelin, & triptorelin LHRH analogues in the treatment of prostate cancer in adults 7 20170901 01/09/2017 20200401 01/04/2020
Lisdexamfetamine Lisdexamfetamine for ADHD in children and adolescents 4 20170801 01/08/2017 20200801 01/08/2020
Lithium Lithium for patients over 18 years old including those aged 65 years and older 4 20171201 01/12/2017 20201201 01/12/2020
Testosterone Masculinising hormones for patients aged 17 years or over under Indigo Gender Service 6 20210301 01/03/2021 20240301 01/03/2024
Melatonin Melatonin for children and adolescents 4 20170901 01/09/2017 20200201 01/02/2020
Methylphenidate Methylphenidate for ADHD in children and adolescents 4 20170801 01/08/2017 20200801 01/08/2020
Mycophenolate Mycophenolate for interstitial lung disease in adults 10 20210901 01/09/2021 20240801 01/08/2024
Mycophenolate mofetil Mycophenolate mofetil for rheumatological conditions in adults 10 20171101 01/11/2017 20201001 01/10/2020
Mycophenolate mofetil Mycophenolate mofetil in dermatology in adults 13 20180201 01/02/2018 20210201 01/02/2021
Colistimethate Nebulised colistimethate in adult patients with non-CF bronchiectasis or bronchial sepsis 5 20170901 01/09/2017 20200601 01/06/2020
Methotrexate Oral methotrexate for IBD in adults 1 20181001 01/10/2018 20211001 01/10/2021
Methotrexate Oral methotrexate for rheumatological conditions in adults 10 20171101 01/11/2017 20201001 01/10/2020
Methotrexate Oral methotrexate for sarcoid in adults 3 20210901 01/09/2021 20240801 01/08/2024
Methotrexate Oral methotrexate in dermatology in adults 13 20180701 01/07/2018 20210701 01/07/2021
Antipyschotics Oral second generation (atypical) antipsychotics for adults 4 20170901 01/09/2017 20180401 01/04/2018 Update in progress
Paliperidone Paliperidone long-acting antipsychotic injection 4 20191101 01/11/2019 20221101 01/11/2022
Penicillamine Penicillamine for the treatment of rheumatoid arthritis or Wilson’s disease in adults Misc 20200101 01/01/2020 20230101 01/01/2023
Riluzole Riluzole for amyotrophic lateral sclerosis 4 20191101 01/11/2019 20221101 01/11/2022
Risperidone Risperidone long-acting antipsychotic injection in adults 4 20170801 01/08/2017 20200801 01/08/2020
SSRIs SSRIs for the treatment of anxiety disorders in children and adolescents 4 20171001 01/10/2017 20201001 01/10/2020
SSRIs SSRIs for the treatment of depression in children and adolescents 4 20171001 01/10/2017 20201001 01/10/2020
SSRIs SSRIs for the treatment of OCD and body dysmorphic disorder (BDD) in children and adolescents 4 20171001 01/10/2017 20201001 01/10/2020
Sulfasalazine Sulfasalazine for inflammatory bowel disease in adults 1 20180801 01/08/2018 20210801 01/08/2021
Sulfasalazine Sulfasalazine in rheumatological conditions in adults 10 20171101 01/11/2017 20201001 01/10/2020